Product Image

Extra Strength Ginkgo 120 mg

Doctor's Best
4.7
★ ★ ★ ★ ★
(145321 ratings)
Ginkgo
Product Image
Score81
A full-serving, value-oriented ginkgo extract with good cognitive relevance. Missing marker percentages and purity specifications are the main limitations.
How scoring works
Quantity:120 Veggie Cap(s) • (120 servings)
Goals:
Mental Focus
Cognitive Support
Productivity Boost
Brain Health

Score 81

A full-serving, value-oriented ginkgo extract with good cognitive relevance. Missing marker percentages and purity specifications are the main limitations.
How scoring works
$12.99($0.10 per serving)
Amazon
$ 12.99
Pure Formulas
$ 21.67
iHerb
$ 12.99
Vitacost
$ 14.29
iHerb
$ 12.99
Report prices

Analysis

The capsule provides 120 mg of ginkgo extract, matching a commonly used daily amount. Flavonol glycosides and terpene lactones are identified, but exact standardization percentages are absent.

Ginkgo may support memory, attention, and processing through cerebral circulation, especially for older users or circulation-related needs. It is not a reliable stimulant-like productivity aid, and its vision role remains indirect.

The focused formula suits users who want a substantial ginkgo serving without unrelated ingredients. A broader cognitive product may be preferable for stress resilience, energy, or multiple neurotransmitter pathways.

Who is it for
  • Adults seeking a full ginkgo serving
  • People focused on memory and attention
  • Value-conscious nootropic users
Best for
  • Cerebral-circulation support
  • Longer-term cognitive routines
  • Single-ingredient ginkgo use

Pros

  • Provides a commonly used daily amount
  • Names both key marker classes
  • Focused capsule with strong practical value

Cons

  • Marker percentages are not stated
  • No ginkgolic-acid purity limit
  • Covers only one main cognitive pathway

Warnings

  • Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines such as warfarin, apixaban, aspirin, or clopidogrel.
  • Bleeding risk can also matter around surgery, so perioperative use should be reviewed.
  • Headache, dizziness, or digestive discomfort may occur.

Nutrient quality

83 Highest impact

The key ginkgo marker groups are named, but their percentages and a purity limit are not fully disclosed. The formula supplies a full target-range extract amount, with no obvious overdosing.

.

Ingredient transparency

80 High impact

The main active amounts are clearly listed, and no proprietary blend hides them. Intake directions, non-active ingredients, and some extract-quality details are absent from the supplied data.

.

Customer satisfaction

70 High impact

The supplied average is strong and the response volume is very large. No detailed feedback is provided to assess recurring complaints or fit with the intended purpose.

.

Value for money

88 Highest impact

The serving cost is appealing, but incomplete extract verification limits confidence in value. The formula compares favorably with many category alternatives.

.
Report analysis

Goals

Mental Focus
Impact
Highest effect
B Goal FitA- Strength of SupportC CoverageA Formula Quality

A standardized ginkgo extract provides a plausible cerebral-blood-flow pathway for attention and processing speed. Human findings are mixed in healthy adults and appear more useful in older people or those with cognitive concerns.

The serving amount matches common studied use, and the main marker groups are identified. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines, making that interaction important before regular use.

Study evidence
Ginkgo Supportive 28 studies
Cognitive Support
Impact
High effect
A- Goal FitB+ Strength of SupportD+ CoverageA Formula Quality

Ginkgo directly supports cerebral circulation and has relevant human evidence for memory and attention, especially in older populations. The 120 mg extract amount is aligned with common clinical use.

Flavonol glycosides and terpene lactones are named, but their percentages and a ginkgolic acid limit are absent. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 87 studies
Productivity Boost
Impact
High effect
B- Goal FitB+ Strength of SupportC CoverageA Formula Quality

The 120 mg ginkgo extract amount falls within a commonly studied range and may support cerebral circulation and selected cognitive functions. Flavonol glycosides and terpene lactones are named, giving the extract some useful marker context.

The label does not provide marker percentages or a ginkgolic-acid purity limit, so it cannot be matched confidently to well-studied standardized extracts. Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines such as warfarin, apixaban, aspirin, or clopidogrel.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Brain Health
Impact
High effect
C+ Goal FitB+ Strength of SupportD+ CoverageA+ Formula Quality

The 120 mg ginkgo extract amount matches a commonly used clinical range for circulation-related cognitive support. Flavonol glycosides and terpene lactones are named, but their percentages and a ginkgolic-acid purity limit are missing.

The formula is focused and substantial within one pathway but does not provide broader cognitive support. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Vision Support
Impact
Moderate effect
D Goal FitB- Strength of SupportD- CoverageB- Formula Quality

Ginkgo may support ocular blood flow in specific vascular situations, but it is not broad vision support. Evidence for meaningful visual outcomes remains more limited than for macular carotenoids or established antioxidant combinations.

The standardized extract reaches a commonly used serving, though marker percentages and a purity limit are not disclosed. Ginkgo can increase bleeding risk with anticoagulant or antiplatelet medicines, so that combination deserves specific medical review.

Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per serving
Ginkgo extract (Flavonol Glycosides, Terpene Lactones)
120 mg
Gluten Free Adults 18–50 Vegan Vegetarian
Report overview
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

The full clinical extract amount is clearly disclosed and comes at a very low serving cost. Both active-marker groups are named, but their percentages and a ginkgolic-acid purity limit are missing. Ginkgo may raise bleeding risk with anticoagulants or antiplatelet drugs, so concurrent use requires specific medical review.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  2. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P · Journal of clinical epidemiology · 2003
    Randomized trial214 participantsBrain Health forGinkgo
  3. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledBrain Health Cognitive Support Productivity Boost forGinkgo
  4. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  5. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
    Laws KR; Sweetnam H; Kondel TK · Human psychopharmacology · 2014
    Meta-analysis1,132 participants13 studies pooledMental Focus forGinkgo
  6. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults.
    Burns NR; Bryan J; Nettelbeck T · Human psychopharmacology · 2006
    Randomized trial197 participantsMental Focus forGinkgo
  7. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledProductivity Boost Brain Health forGinkgo
  8. Effects of Ginkgo biloba on alertness and chemosensory function in healthy adults.
    Mattes RD; Pawlik MK · Human psychopharmacology · 2004
    Randomized trial39 participantsProductivity Boost forGinkgo
  9. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  10. Ginkgo biloba--an appraisal.
    Dubey AK; Shankar PR; Upadhyaya D; Deshpande VY · Kathmandu University medical journal (KUMJ) · 2007
    Narrative reviewVision Support forGinkgo
  11. Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.
    Page JW; Findley J; Crognale MA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006
    Clinical trialVision Support forGinkgo
  12. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  13. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  14. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  15. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  16. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  17. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  18. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  19. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  20. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  21. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  22. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  23. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  24. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  25. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  26. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  27. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  28. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo
  29. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  30. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  31. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  32. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo